🎯Oncology (General)
Cancer-focused biotechs developing novel therapies including immunotherapies, targeted therapies, and combination treatments.
Market Cap$447.1B
1D-2.03%
Companies950
Public Cos171
SECTOR MARKET CAP
$447.1B+15558.8%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $163.2B | GILD |
| 2 |  | United States | $32.9B | ONC |
| 3 |  | United States | $30.4B | RVMD |
| 4 |  | China | $19.9B | 1801.HK |
| 5 |  | Denmark | $16.3B | GMAB |
| 6 |  | France | $16.2B | IPN.PA |
| 7 |  | China | $16.1B | 688506.SS |
| 8 |  | United Kingdom | $13.6B | SMMT |
| 9 |  | United States | $12.6B | GH |
| 10 |  | United States | $11.8B | EXEL |
| 11 |  | China | $9.0B | 002653.SZ |
| 12 |  | United States | $8.4B | NUVL |
| 13 |  | Japan | $7.8B | 4151.T |
| 14 |  | United States | $6.1B | CGON |
| 15 |  | United States | $6.1B | TERN |
| 16 |  | United States | $6.0B | LNTH |
| 17 |  | United States | $4.5B | CAI |
| 18 |  | United States | $3.1B | VCYT |
| 19 |  | Finland | $2.6B | ORNAV.HE |
| 20 |  | United States | $2.6B | ELVN |